Requirements and challenges of a preclinical autoimmune hepatitis mouse model

Digestive Diseases

Volumn 29, Issue 4, 2011, Pages 402-410

  Hardtke Wolenski, Matthias ^a   Noyan, Fatih ^a   Jaeckel, Elmar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune hepatitis; Pathophysiology; Transgenic models

Indexed keywords

ANTIGEN; AZATHIOPRINE; CYTOKINE; STEROID;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LIVER CELL; LIVER SINUSOID; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIGENS; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; HEPATITIS, AUTOIMMUNE; IMMUNITY; IMMUNIZATION; MICE;

EID: 80052468995     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000329804     Document Type: Article

References (84)

1. Calne RY, et al: Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
2. Mazariegos GV, et al: Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63: 243-249. (Pubitemid 27121206)
3. Pons JA, et al: Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients. Clin Transplant 2009; 23: 329-336.
4. Tryphonopoulos P, et al: The impact of Campath 1H induction in adult liver allotransplantation. Transplant Proc 2005; 37: 1203-1204. (Pubitemid 40590836)
5. Qian S, et al: Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994; 19: 916-924. (Pubitemid 24109354)
6. Kamada N: The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369-389. (Pubitemid 15058228)
7. Alvarez F, et al: International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938. (Pubitemid 29514229)
8. Ichiki Y, et al: Is primary biliary cirrhosis a model autoimmune disease? Autoimmun Rev 2004; 3: 331-336. (Pubitemid 38887629)
9. Park BK, Kitteringham NR: Drug-protein conjugation and its immunological consequences. Drug Metab Rev 1990; 22: 87-144. (Pubitemid 20211495)
10. Nelson SD, Pearson PG: Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 1990; 30: 169-195.
11. Bowen DG, et al: The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712. (Pubitemid 39578761)
12. Shibolet O, et al: The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin Immunol 2004; 111: 82-92. (Pubitemid 38482085)
13. Limmer A, et al: Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific Tcell tolerance. Nat Med 2000; 6: 1348-1354. (Pubitemid 32001018)
14. Crispe IN: Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3: 51-62. (Pubitemid 37328699)
15. Chen CH, et al: In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006; 44: 1171-1181.
16. Lüth S, et al: Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008; 118: 3403-3410.
17. Scheiffarth F, Warnatz H, Mayer K: Studies concerning the importance of mononuclear cells in the development of experimental hepatitis. J Immunol 1967; 98: 396-401.
18. Warnatz H, Scheiffarth F, Schmeissner R: Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells. Clin Exp Immunol 1975; 21: 250-258.
19. Kuriki J, et al: Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae Gastroenterology 1983; 84: 596-603. (Pubitemid 13191914)
20. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045. (Pubitemid 24140436)
21. Mori Y, et al: Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol 1984; 57: 85-92. (Pubitemid 14083831)
22. Mori Y, et al: Study of cellular immunity in experimental autoimmune hepatitis in mice: Transfer of spleen cells sensitized with liver proteins. Clin Exp Immunol 1985; 61: 577-584. (Pubitemid 16252334)
23. Mori T, et al: Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells - in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis. Hepatology 1985; 5: 770-777. (Pubitemid 15236620)
24. Watanabe Y, et al: Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice. Clin Exp Immunol 1987; 67: 105-113. (Pubitemid 17222167)
25. Asano M, et al: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387-396. (Pubitemid 26324092)
26. Lohse AW, et al: Experimental autoimmune hepatitis: Disease induction, time course and T-cell reactivity. Hepatology 1990; 11: 24-30. (Pubitemid 20075097)
27. Lohse AW, Meyer zum Buschenfelde KH: Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression. Clin Exp Immunol 1993; 94: 163-167. (Pubitemid 23308383)
28. Lohse AW, Kogel M, Meyer zum Buschenfelde KH: Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 1995; 22: 381-388.
29. Suri-Payer E, et al: CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-1218. (Pubitemid 28093417)
30. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296. (Pubitemid 28357757)
31. Lohse AW, Dienes HP, Meyer zum Buschenfelde KH: Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology 1998; 27: 1536-1543.
32. Tiegs G: Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg 1997; 60: 176-179. (Pubitemid 27305269)
33. Toyonaga T, et al: Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci USA 1994; 91: 614-618. (Pubitemid 24041452)
34. Hussain MJ, et al: Cellular expression of tumour necrosis factor-alpha and interferongamma in the liver biopsies of children with chronic liver disease. J Hepatol 1994; 21: 816-821. (Pubitemid 24374149)
35. Tiegs G, Hentschel J, Wendel A: A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
36. Kusters S, et al: Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111: 462-471. (Pubitemid 26256736)
37. Gantner F, et al: Concanavalin A-induced Tcell- mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995; 21: 190-198.
38. Gantner F, et al: T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 1996; 229: 137-146. (Pubitemid 26423942)
39. Knolle PA, et al: Role of sinusoidal endothelial cells of the liver in concanavalin Ainduced hepatic injury in mice. Hepatology 1996; 24: 824-829. (Pubitemid 26334281)
40. Takeda K, et al: Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97: 5498-5503. (Pubitemid 30313747)
41. Gantner F, et al: Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995; 109: 166-176.
42. Leist M, et al: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994; 153: 1778-1788. (Pubitemid 24251123)
43. Kuhn R, et al: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274. (Pubitemid 23320290)
44. Shull MM, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
45. Gorham JD, et al: Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 2001; 166: 6413-6422. (Pubitemid 32440776)
46. Clemente MG, et al: Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998; 114: 324-328. (Pubitemid 28093540)
47. Clemente MG, et al: Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1997; 82: 1353-1361. (Pubitemid 27200400)
48. Obermayer-Straub P, et al: Hepatic autoantigens in patients with autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. Gastroenterology 2001; 121: 668-677. (Pubitemid 32822582)
49. Hardtke-Wolenski M, et al: The impact of AIRE deficiency related to liver-specific immune responses. EASL Monothematic Conference: Immune Mediated Liver Injury, Hamburg, 2008.
50. Derbinski J, et al: Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039. (Pubitemid 33069498)
51. Klein L, et al: CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998; 188: 5-16. (Pubitemid 28328601)
52. Klein L, Kyewski B: 'Promiscuous' expression of tissue antigens in the thymus: A key to T-cell tolerance and autoimmunity? J Mol Med 2000; 78: 483-494.
53. Jones-Youngblood SL, et al: Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance. J Immunol 1990; 144: 1187-1195. (Pubitemid 20072882)
54. Wieties K, et al: Peripheral tolerance in mice expressing a liver-specific class I molecule: Inactivation/deletion of a T-cell subpopulation. Proc Natl Acad Sci USA 1990; 87: 6604-6608.
55. Morahan G, et al: Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci USA 1989; 86: 3782-3786. (Pubitemid 19141829)
56. Moriyama T, et al: Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248: 361-364.
57. Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
58. Chisari FV: Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 1996; 206: 149-173. (Pubitemid 26025611)
59. Wirth S, et al: Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J Immunol 1995; 154: 2504-2515.
60. Shimizu Y, et al: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998; 161: 4520-4529. (Pubitemid 28492022)
61. Ferber I, et al: Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 1994; 263: 674-676. (Pubitemid 24076292)
62. Schönrich G, et al: Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293-304. (Pubitemid 121006059)
63. Schönrich G, et al: Tolerance induction as a multi-step process. Eur J Immunol 1994; 24: 285-293. (Pubitemid 24041113)
64. Alferink J, et al: Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int Immunol 1995; 7: 331-336.
65. Schönrich G, et al: Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 1992; 4: 581-590.
66. Heath WR, et al: Autoimmune diabetes as a consequence of locally produced interleukin- 2. Nature 1992; 359: 547-549.
67. Holz LE, et al: Intrahepatic murine CD8 Tcell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 2008; 135: 989-997.
68. Oldstone MB, et al: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 1991; 65: 319-331. (Pubitemid 121006061)
69. Voehringer D, et al: Break of T cell ignorance to a viral antigen in the liver induces hepatitis. J Immunol 2000; 165: 2415-2422. (Pubitemid 30660685)
70. Ohashi PS, et al: Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305-317. (Pubitemid 121006060)
71. Knolle PA, et al: Induction of cytokine production in naive CD4(+) T cells by antigenpresenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999; 116: 1428-1440. (Pubitemid 29258892)
72. Lohse AW, et al: Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996; 110: 1175-1181. (Pubitemid 26113757)
73. Zierden M, Kühnen E, Odenthal EK, Dienes HP: Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis. Gastroenterology 2010; 139: 975-986, 986.e1-986.e3.
74. Manns MP, et al: Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989; 83: 1066-1072. (Pubitemid 19080643)
75. Zanger UM, et al: Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 1988; 85: 8256-8260.
76. Oldstone MB: Molecular mimicry and autoimmune disease. Cell 1987; 50: 819-820.
77. Rose NR, Mackay IR: Molecular mimicry: A critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000; 57: 542-551. (Pubitemid 30311425)
78. Oldstone MB: Molecular mimicry and immune- mediated diseases. FASEB J 1998; 12: 1255-1265. (Pubitemid 28475568)
79. Croxford JL, Anger HA, Miller SD: Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol 2005; 174: 907-917. (Pubitemid 40094286)
80. Christen U, et al: A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004; 114: 1290-1298. (Pubitemid 40385300)
81. Holdener M, et al: Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008; 205: 1409-1422. (Pubitemid 351831496)
82. Limmer A, et al: Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment. Eur J Immunol 1998; 28: 2395-2406. (Pubitemid 28362714)
83. Sacher T, et al: CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur J Immunol 2002; 32: 3628-3637. (Pubitemid 36024399)
84. Fischer K, et al: A new animal model of chronic autoimmune hepatitis mediated by the adaptive immune system (abstract). Z Gastroenterol 2009;47:151.